The National Hospital for Neurology and Neurosurgery, U.K. recently conducted a meeting wherein the main topic of discussion was a neurological drug that has the capacity to even treat multiple sclerosis which stems from associated eye related conditions and anomalies. Acute optic neuritis refers to an eye condition which involves the inflammation of that nerve which transports visual information to the human brain from eyes. This is a commonly occurring anomaly that affects most people suffering from multiple sclerosis.
This eye problem can lead to either partial or full blindness. It also sometimes leads to blackened or for that matter even foggy vision and sometimes even pain. In many instances even though a person regains his eyesight there is still some amount of nerve damage that takes place. In fact with ach attack, the strength of the eye and its visual capacities get affected. Generally steroids are used for treating acute optic neuritis in order to speed up the process of vision recovery. But as per medical observations, this treatment does not lead to full recovery of the eyes.
In fact, there is a big gap in the incidence of this visual anomaly and the course of treatment for the same. There is an unmet demand for therapy that will prevent further damage in the eye. Phenytoin is a drug that is basically an antiepileptic and an anticonvulsant that helps in controlling seizures and epileptic fits via the slowing down of impulses within the brain that cause these seizures.
The observational tests were conducted on a group of 86 persons who were suffering from acute optic neuritis. They were given Phenytoin or even a placebo soon within two weeks of the onset of the symptoms. It was observed by the medical researchers that those patients who were given Phenytoin experienced lower degree of eye damage by almost 30% as against those patients who received the placebo.